Muhammad Usman Almani
Clinical FellowAbout
Research
Publications
2026
Sinus of Valsalva Aneurysm A Rare Mechanical Cause of Right Ventricular Outflow Tract Obstruction
Antia A, Almani M, Bozorgnia B, Chamoun A. Sinus of Valsalva Aneurysm A Rare Mechanical Cause of Right Ventricular Outflow Tract Obstruction. JACC Case Reports 2026, 31: 107947. PMID: 41999370, PMCID: PMC13221885, DOI: 10.1016/j.jaccas.2026.107947.Peer-Reviewed Original ResearchImpact of Left Ventricular Diastolic Function on Right Ventricular Size and Function
Almani M, Romero A, Akuna E, Suarez A, Isaacs E, Chikovani N, Malin J, Pereira L, Hazim C, Alzubi J, Port Z, Pressman G. Impact of Left Ventricular Diastolic Function on Right Ventricular Size and Function. Journal Of The American Society Of Echocardiography 2026, 39: 345-354. PMID: 41485609, DOI: 10.1016/j.echo.2025.12.015.Peer-Reviewed Original ResearchSocioeconomic Disparities in Readmission Outcomes and Cardiac Procedures Among Atrial Fibrillation Hospitalizations
Almani M, Yousuf M, Fatima N, Ullah M, Arshad M. Socioeconomic Disparities in Readmission Outcomes and Cardiac Procedures Among Atrial Fibrillation Hospitalizations. Advances In Public Health 2026, 2026 DOI: 10.1155/adph/4771111.Peer-Reviewed Original Research
2025
Extensive coronary-cameral fistulas and incidental left ventricular papillary fibroelastoma
Almani M, Ahluwalia V, Yousuf M, Alzubi J, Stempniewicz P, Chamoun A. Extensive coronary-cameral fistulas and incidental left ventricular papillary fibroelastoma. BMJ Case Reports 2025, 18: e269899. PMID: 41475864, DOI: 10.1136/bcr-2025-269899.Peer-Reviewed Original ResearchImpact of Alcohol Septal Ablation on Clinical Outcomes in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Transcatheter Aortic Valve Replacement
Almani M, Ahluwalia V, Yousuf M, Alzubi J, Bonita R, Witzke C. Impact of Alcohol Septal Ablation on Clinical Outcomes in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Transcatheter Aortic Valve Replacement. Catheterization And Cardiovascular Interventions 2025, 107: 465-466. PMID: 41340026, DOI: 10.1002/ccd.70388.Commentaries, Editorials and LettersClinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy
Almani M, Ahluwalia V, Yousuf M, Alzubi J, Hamza M, Bonita R, Witzke C. Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy. Catheterization And Cardiovascular Interventions 2025, 106: 3419-3426. PMID: 40988349, PMCID: PMC12679522, DOI: 10.1002/ccd.70201.Peer-Reviewed Original ResearchAgedAged, 80 and overAortic ValveAortic Valve StenosisCardiomyopathy, HypertrophicComorbidityDatabases, FactualFemaleHospital MortalityHumansMalePatient ReadmissionPostoperative ComplicationsRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeUnited StatesImpact of Tricuspid Regurgitation on the Clinical Outcomes of Patients with Heart Failure
Almani M, Khan R, Fatima N, Yousuf M, Amanullah A. Impact of Tricuspid Regurgitation on the Clinical Outcomes of Patients with Heart Failure. Public Health Challenges 2025, 4: e70092. PMID: 40969311, PMCID: PMC12442787, DOI: 10.1002/puh2.70092.Peer-Reviewed Original ResearchOptimizing P2Y12 Inhibitor Therapy in Post-PCI Patients Through Genotype-Guided Strategies: A Systematic Review and Meta-Analysis
Hamza M, Karamat M, Harmouch K, Alamzaib S, Jabeen S, Basit J, Bhanushali K, Ved R, Rashdi A, Almani M, Syed M, Sattar Y, Alraies M. Optimizing P2Y12 Inhibitor Therapy in Post-PCI Patients Through Genotype-Guided Strategies: A Systematic Review and Meta-Analysis. Cardiovascular Drugs And Therapy 2025, 40: 933-942. PMID: 40788330, DOI: 10.1007/s10557-025-07747-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2024
Pulmonary artery pressure sensor device performance in patients with atrial fibrillation/flutter
Almani M, Alzubi J, Yousuf M, Alrawashdeh R, Fatima N, Al Madani M, Bonita R. Pulmonary artery pressure sensor device performance in patients with atrial fibrillation/flutter. Global Cardiology 2024, 2 DOI: 10.4081/cardio.2024.55.Peer-Reviewed Original ResearchPrevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
Almani M, Talha K, Khan L, Hameed I, Asad Z, Fudim M, Krasuski R, Khan M. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter. The American Journal Of Cardiology 2024, 222: 29-34. PMID: 38636626, DOI: 10.1016/j.amjcard.2024.04.009.Peer-Reviewed Original Research